Showcasing LRRK2 Inhibitors as Treatment for Parkinson’s Disease
Time: 2:30 pm
day: Day 2 afternoon
Details:
- Exploring the role of LRRK2 in the pathophysiology of Parkinson’s disease
- Uncovering case studies which showcase the benefit of therapeutic approaches to inhibit LRRK2
- Revealing how new small molecule inhibitors of LRRK2 can be used to treat Parkinson’s disease
